3640
I. Izquierdo et al. / Tetrahedron: Asymmetry 15 (2004) 3635–3642
5.1mmol) was added, and the reaction mixture stirred
for 3h. TLC (Et2O) then revealed a faster-running com-
pound. The mixture was then partitioned into water
(10mL) and Et2O (40mL). The organic phase was sepa-
rated and then concentrated. Column chromatography
2), 3.63 (t, 1H, J1,2 = J1,7a = 5.8Hz, H-1), 3.22 (dd, 1H,
H-3a), 3.20 (q, 1H, H-7a), 2.91 (dt, 1H, J5a,6a
=
J
5a,6b = 6, J5a,5b 10.4Hz, H-5a), 2.72 (dt, 1H,
5b,6a = J5b,6b = 6.5Hz, H-5b), 2.53 (dd, 1H, J3a,3b
6a,7a = J6b,7a
J7a,7a = 6.3, J7a,7b 13.6Hz, H-7a),1.88 (dquin, 1H,
5a,6b = J5b,6b = J6b,7b = 5.7, J6a,6b 12.0Hz, H-6b), 1.78
J
10.5Hz, H-3b), 1.96 (dq, 1H,
J
=
(Et2O–hexane, 3:1) of the residue afforded pure 17
22
(420mg, 95%) as a colorless syrupy oil; ½a ¼ þ44 (c
J
D
1). IR (neat): 3032 (aromatic), and 1707cmÀ1 (C@O,
lactam). NMR data (400MHz): 1H, 7.40–7.27 (m,
10H, 2CH2Ph), 5.10 and 4.79 (2d, 2H, J 11.6Hz,
CH2Ph), 4.62 and 4.56 (2d, 2H, J 11.8Hz, CH2Ph),
4.48 (d, 1H, J1,2 8.0Hz, H-2), 3.89 (dd, 1H, J1,7a
6.5Hz, H-1), 3.61–3.54 (m, 2H, H-5,7a), 3.04 (m, 1H,
H-50), 2.10–1.86 (m, 3H, H-6,60,7), and 1.42 (dq, 1H,
(dq, 1H, J7 a,7b = J6a,7b = 6.5Hz, H-7b), and 1.70 (dquin,
1H, H-6a). 13C (100MHz), d 82.93 (C-1), 78.63
(C-2), 70.74 (C-7a), 59.62 (C-3), 56.64 (C-5), 31.43
(C-7), and 26.23 (C-6). Anal. Calcd for C7H13NO2: C,
58.72; H, 9.15; N, 9.78. Found: C, 58.45; H, 9.31; N,
10.00.
J6,7 = J6 ,7 = J7 ,7a = 8.6, J7,7 12.1Hz, H-70); 13C
(100MHz): d 170.8 (C-3), 137.80, 137.60, 128.52,
128.40, 128.26, 127.99, 127.81, and 127.78 (CH2Ph),
86.82 (C-1), 84.14 (C-2), 72.70 and 72.44 (CH2Ph),
62.03 (C-7a), 41.55 (C-5), 31.02 (C-7), and 25.82 (C-6).
Mass spectrum (LSIMS): m/z: 360.1578 [M++Na] for
C21H23NO3Na 360.1576 (deviation À 0.7).
0
0
0
0
0
3.12. Methyl (2S,3S)-20 and (2R,3R)-2,3-dihydroxy-3-
[(20S)-N-benzyloxycarbonylpyrrolidin-20-yl]propanoate
21
3.12.1. Dihydroxylation of
6 without chiral cata-
lyst. Compound 6 (1.4g, 4.84mmol) was hydroxylated
as for 7 in acetone–water 8:1 v/v (18mL), with N-oxide-
N-methylmorpholine (1.13g, 9.64mmol) and aqueous
1% OsO4 (4mL). The mixture was left at room temper-
ature overnight. GLC11 (B) then revealed the presence of
two new products (tR 17.33 and 17.67min) in a 1:4 ratio.
The mixture was concentrated to a residue that was sub-
mitted to chromatography (Et2O–hexane, 2:1). Eluted
3.10. (1S,2S,7aS)-1,2-Dibenzyloxypyrrolizidine 18
To a stirred solution of 17 (250mg, 0.74mmol) in anhy-
drous THF (6mL) was added LiAlH4 (56mg, 1.4mmol),
and the mixture refluxed overnight. TLC (Et2O) then re-
vealed that no starting material was present. Aqueous
0.5M NaOH (2mL) was cautiously added and the mix-
ture partitioned into EtAcO (5mL) and water (5mL).
The organic phase was separated and the aqueous ex-
tracted with EtAcO (3 · 5mL). The combined extracts
were concentrated and the residue submitted to column
firstwas pure 20 (160mg, 10%) as a colorless syrup; tR
25
D
17.33min; ½a ¼ À51 (c 1.25). IR (neat): 3402 (OH),
3032 (aromatic), 1746 and 1669 (C@O), and 699cmÀ1
1
(aromatic). NMR data (400MHz): H, d 7.34 (m, 5H,
Ph), 5.13 (s, 2H, CH2Ph), 4.96 (br d, 1H, J 6.5Hz,
HO), 4.23 (dt, 1H, J 3.8, J 7.8Hz, H-20), 4.10 (m, 2H,
H-2, OH), 3.80 (br s, 4H, OMe, H-3), 3.59 (dt, 1H,
chromatography (Et2O–MeOH, 20:1) to afford pure 18
26
(180mg, 75%) as a colorless syrup; ½a ¼ À4 (c 1). IR
J4 a,5 a = J4 b,5 a = 7.4, J5 a,5 b 10.7Hz, H-50a), 3.39
D
0
0
0
0
0
0
(neat): 3029cmÀ1 (aromatic). NMR data (300MHz):
1H, d 7.34 (m, 10H, 2CH2Ph), 4.60 and 4.57 (2d, 2H,
J 11.8Hz, CH2Ph), 4.63 (s, 2H, CH2Ph), 4.21 (q, 1H,
(ddd, 1H, J4 a,5 b 5.3, J4 b,5 b 7.3Hz, H-50b), 2.11–2.00,
1.92–1.86, and 1.84–1.75 (3m, 4H, H-30a,30b,40a,40b);
13C (100MHz), d 173.48 (C-1), 158.07 (Cbz), 136.21,
128.61, 128.26, 127.99 (Ph), 77.12 (C-3), 72.47 (C-2),
67.76 (CH2Ph), 58.48 (C-20), 52.58 (OMe), 47.83 (C-
50), 29.07 and 24.37 (C-30,40). Mass spectrum (LSIMS):
m/z: 346.1263 [M++Na] for C16H21NO6Na 346.1267
(deviation + 0.9ppm).
0
0
0
0
0
J1,2 = J2,3 = J2,3 = 5.7Hz, H-2), 3.80 (t, 1H, J1,7a 5Hz,
H-1), 3.47 (br q, 1H, J 5.0Hz, H-7a), 3.37 (dd, 1H,
0
J3,3 10.2Hz, H-3), 3.04 (m, 1H, H-5), 2.76–2.69 (m,
2H, H-30,50), 2.05–1.95 (m, 1H, H-7), 1.94–1.85 (m,
1H, H-6), and 1.83–1.64 (m, 2H, H-60,70); 13C
(75MHz, inter alia): d 88.46 (C-1), 84.99 (C-2), 72.11
and 71.83 (CH2Ph), 68.52 (C-7a), 57.13 (C-3), 55.45
(C-5), 31.18 (C-7), and 25.88 (C-6). Mass spectrum
(LSIMS): m/z: 324.1958 [M++1] for C21H26NO2
324.1964 (deviation + 1.8ppm).
Eluted second was pure 21 (1.1g, 70%) as a colorless syr-
24
D
up; tR 17.67min; ½a ¼ À48 (c 1). IR (neat): 3393 (OH),
3033 (aromatic), 1742 (C@O, ester), 1674 (C@O, Cbz),
1
and 699cmÀ1 (aromatic). NMR data (400MHz): H, d
7.34 (m, 5H, Ph), 5.15 and 5.08 (2d, 2H, J 12.3Hz,
CH2Ph), 4.27 (br s, 1H, H-2), 3.99 (br s, 2H, H-3,20),
3.63 (s, 3H, OMe), 3.39 (m, 1H, H-50a), 3.16 (m, 1H,
H-50b), 2.08 and 1.90 (2m, 4H, H-30a,30b,40a,40b); 13C
(100MHz): d 172.44 (C-1), 156.96 (Cbz), 136.13,
128.59, 128.27, 128.13 (Ph), 73.75 (C-3), 73.66 (C-2),
67.80 (CH2Ph), 59.75 (C-20), 52.25 (OMe), 46.67 (C-
50), 27.73 and 23.39 (C-30,40). Mass spectrum (LSIMS):
m/z: 346.1267 [M++Na] for C16H21NO6Na 346.1267
(deviation 0.0ppm).
3.11. (1S,2S,7aS)-1,2-Dihydroxypyrrolizidine 19
A solution of 18 (275mg, 0.85mmol) in MeOH (10mL)
was acidified with concd HCl and stirred at rt with 10%
Pd–C (75mg) in an H2 atmosphere overnight. TLC
(Et2O–MeOH–Et3N, 2:1:0.1) then showed that 18 had
disappeared. The catalyst was filtered off and washed
with MeOH. The mixture was neutralized with Amber-
lite IRA-400, the resin filtered off, washed with MeOH
and the filtrate and washings concentrated to afford 19
(107mg, 88%) as white crystals, mp 164–165ꢂC
23
(from Et2O–MeOH); ½a ¼ þ11 (c 0.5, MeOH). Lit.5b
3.12.2. Dihydroxylation of 6 with chiral catalyst. Com-
pound 6 (50mg, 170lmol) was dihydroxylated under the
same conditions as 7 (see above) to yield mixtures of 20
D
24
D
½a ¼ À3:4 (c 0.5, MeOH). NMR data (400MHz,
1
MeOH-d4): H, d 4.03 (q, 1H, J2,3a = J2,3b = 5.8Hz, H-